Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register PHARMAC for InfoPages here.
PHARMAC - Latest News [Page 3]
Pharmac Confirms Widened Access To The Funded Flu Vaccine
Thursday, 2 March 2023, 12:14 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac is widening access to the annual funded flu vaccine to tamariki aged 6 months to 12 years and will again offer it to Māori and Pacific peoples who are 55 to 64 years of age for the 2023 flu season. “The flu vaccine ... More >>
Pharmac Shares Agenda Items For The Upcoming Rare Disorders Committee Meeting
Monday, 27 February 2023, 1:36 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac is creating visibility of what medicines are being considered that could impact the rare disorders community by sharing the agenda items for the upcoming Rare Disorders Advisory Committee meeting. Pharmac’s Chief Medical ... More >>
Pharmac Proposing To Phase Out Food Thickeners
Wednesday, 22 February 2023, 1:00 pm | PHARMAC
Today Te Pātaka Whaioranga - Pharmac is beginning a consultation to better understand how phasing out the funding of food thickeners in the community would affect people who use them. Pharmac’s chief medical officer Dr David Hughes says, “Food thickeners ... More >>
Pharmac Signals First Step Towards Funding Continuous Glucose Monitors
Tuesday, 21 February 2023, 12:11 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac will soon be seeking competitive commercial offers for the supply of funded Continuous Glucose Monitors (CGMs) in New Zealand. “Today we have issued a Future Procurement Opportunity for CGMs, insulin pumps, and insulin ... More >>
Pharmac Seeking Feedback On Funding A Second SMA Treatment
Thursday, 19 January 2023, 7:45 am | PHARMAC
Te Pātaka Whaioranga - Pharmac is initiating a consultation today, seeking feedback on a proposal to fund of risdiplam (branded as Evrysdi) for people with the rare genetic disorder spinal muscular atrophy, who meet the eligibility criteria. Pharmac’s ... More >>
Pharmac Funds More Treatments For People With Inflammatory Bowel Disease
Tuesday, 20 December 2022, 5:16 am | PHARMAC
20 December 2022 Te Pātaka Whaioranga - Pharmac has today announced funding of ustekinumab (branded as Stelara) for people with inflammatory bowel disease (IBD) and the widening of funded access to infliximab (branded as Remicade) for people ... More >>
Pharmac Consulting On Two New Medicines For Lung Cancer
Friday, 16 December 2022, 9:01 am | PHARMAC
Te Pātaka Whaioranga – Pharmac has reached provisional agreements with two different suppliers to fund two medicines to treat New Zealanders with advanced non-small cell lung cancer. The medicines are pembrolizumab (brand name Keytruda) and atezolizumab ... More >>
Pharmac To Fund The EpiPen For Severe Allergies
Thursday, 15 December 2022, 5:22 am | PHARMAC
Te Pātaka Whaioranga - Pharmac has confirmed today that it will be fully funding the EpiPen brand of adrenaline auto injectors from 1 February 2023, which will benefit thousands of New Zealanders. “We are pleased to be able to share that adrenaline ... More >>
Māori Directorate Established At Pharmac
Wednesday, 14 December 2022, 10:35 am | PHARMAC
Te Pātaka Whaioranga – Pharmac has set up a dedicated Māori directorate, demonstrating the strong commitment Pharmac has to ensuring equitable health outcomes for Māori. “We are committed to upholding te Tiriti o Waitangi across all areas of our work. ... More >>
Pharmac Funds More Medicines For New Zealanders
Friday, 9 December 2022, 4:55 am | PHARMAC
08 December Te Pātaka Whaioranga - Pharmac has today announced decisions to fund two new medicines and widen access to one other. These medicines provide a wide range of benefits that will support New Zealanders in living longer, healthier ... More >>
Pharmac Seeking Feedback On Funding Trikafta
Sunday, 4 December 2022, 7:02 pm | PHARMAC
4 December 2022 Te Pātaka Whaioranga – Pharmac has reached a provisional agreement with medicine supplier Vertex to fund Trikafta. “Following our budget increase in May 2022 and commercial negotiations with the supplier, Vertex, I am thrilled ... More >>
Pharmac Welcomes Myeloma NZ As First Patient Advocacy Group To Present To PTAC
Monday, 21 November 2022, 9:50 am | PHARMAC
Myeloma New Zealand presented directly to Pharmac’s Pharmacology and Therapeutics Advisory Committee (PTAC) on Thursday, making them the first patient advocacy group to do so. As Pharmac continues to work to improve its processes around consumer involvement, ... More >>
Pharmac Widens Access To Pneumococcal Vaccine
Monday, 7 November 2022, 1:01 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac has announced today that all young tamariki will receive access to the PCV13 pneumococcal vaccine (brand name Prevenar 13) as part of the childhood immunisation programme, instead of the currently funded PCV10 vaccine ... More >>
Pharmac Seeks Feedback On The Funding Of Paediatric Cancer Medicines
Wednesday, 2 November 2022, 5:18 am | PHARMAC
Te Pātaka Whaioranga Pharmac is seeking feedback on rule 8.1b of the Pharmaceutical Schedule – a unique exception that means any medicine currently used to treat cancer in a paediatric setting is automatically funded without a Pharmac assessment. “We ... More >>
Pharmac Considers Funding Meningococcal B Vaccine To Be Part Of Childhood Immunisations
Tuesday, 25 October 2022, 4:00 pm | PHARMAC
Pharmac today has announced a consultation on widening access to the meningococcal B vaccine (branded as Bexsero) which would give thousands of young people and infants protection against meningococcal B disease. The proposal would allow for its inclusion ... More >>
Pharmac Considering More Options For People With Inflammatory Bowel Disease
Tuesday, 11 October 2022, 5:47 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac has initiated consultation today to fund ustekinumab (branded as Stelara) for people with inflammatory bowel disease (IBD) and to widen access to infliximab (branded as Remicade) for IBD-associated arthritis. “Following ... More >>
Pharmac Seeking Feedback On Nusinersen And Adrenaline Auto-injectors Funding
Wednesday, 28 September 2022, 6:21 am | PHARMAC
Te Pātaka Whaioranga - Pharmac has initiated two consultations today, seeking feedback on the funding of two different medicines that we've heard are very important to many New Zealanders. One is for funding nusinersen (branded as Spinraza) for people ... More >>
Pharmac Considering Multiple New Treatments
Monday, 19 September 2022, 1:48 pm | PHARMAC
Te Pātaka Whaioranga - Pharmac has initiated consultation today on a provisional bundle deal with pharmaceutical manufacturer Takeda to fund vedolizumab for people with inflammatory bowel disease and brentuximab vedotin for people with relapsed ... More >>
Progesterone To Be Fully Funded For All Who Need It
Thursday, 15 September 2022, 10:05 am | PHARMAC
Pharmac has today confirmed that it is removing all funding restrictions from progesterone , with tens of thousands of New Zealanders expected to benefit from access to the hormone replacement therapy. “Up until now progesterone has been funded only for ... More >>
Pharmac Announces Medicines Bundle To Provide More Treatment Options For New Zealanders
Wednesday, 14 September 2022, 12:57 pm | PHARMAC
Te Pātaka Whaioranga – Pharmac is considering funding two medicines as part of a new bundle agreement that would offer new treatment options for people experiencing schizophrenia and for people with one type of blood cancer. In the consultation issued ... More >>
